Elisabet Tina
Elisabet Tina Befattning: Adjungerad universitetslektor Organisation: Institutionen för medicinska vetenskaperE-post: ZWxpc2FiZXQudGluYTtvcnUuc2U=
Telefon: 0721 477557
Rum: X4123
Om Elisabet Tina
Elisabet Tina är docent i medicinsk vetenskap med inriktning biomedicin och adjungerad universitetslektor vid Institutionen för medicinska vetenskaper. Som biobanksansvarig för Örebro biobank verkar även Elisabet vid Örebro universitet kring biobanksrelaterade frågor. Elisabet representerar Örebro universitet och Region Örebro län inom den nationella infrastrukturen Biobank Sverige.
Hennes forskning är huvudsakligen inriktad mot translationell cancerforskning, men omfattar även multipel skleros, sepsis och inflammatorisk tarmsjukdom.
Elisabet undervisar på Läkarprogrammet samt handleder doktorander vid institutionen.
Forskningsprojekt
Pågående projekt
Forskargrupper
Publikationer
Artiklar i tidskrifter
- Lange, N. , Tina, E. , Hultgren, O. , Svenningsson, A. & Gunnarsson, M. (2026). Immunoglobulin-G dynamics and relation to antibiotic prescriptions in multiple sclerosis patients treated with rituximab: a real-world cohort. Multiple Sclerosis and Related Disorders, 107. [BibTeX]
- Alpkvist, H. , Ziegler, I. , Mölling, P. , Tina, E. , Sellvén, L. , Norrby-Teglund, A. , Cajander, S. & Strålin, K. (2024). Damage-associated molecular patterns in bacteraemic infection, including a comparative analysis with bacterial DNA, a pathogen-associated molecular pattern. Scientific Reports, 14 (1). [BibTeX]
- Canhasi, L. , Tina, E. & Göthlin Eremo, A. (2023). Hypoxia-mimetic by CoCl2 increases SLC7A5 expression in breast cancer cells in vitro. BMC Research Notes, 16 (1). [BibTeX]
- Kättström, M. , Uggla, B. , Tina, E. , Kimby, E. , Norén, T. & Athlin, S. (2023). Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia. Vaccine, 41 (9), 3128-3136. [BibTeX]
- Prosén, S. , Tina, E. , Sneckenborg, A. H. , Loinder, C. , Seifert, O. , Lindberg, M. & Göthlin Eremo, A. (2022). Increased expression of LAT1 in basal cell carcinoma: implications for tumour cell survival. Clincal and Experimental Dermatology, 47 (5), 910-917. [BibTeX]
- Törnroos, R. , Tina, E. & Göthlin Eremo, A. (2022). SLC7A5 is linked to increased expression of genes related to proliferation and hypoxia in estrogen‑receptor‑positive breast cancer. Oncology Reports, 47 (1). [BibTeX]
- Göthlin Eremo, A. , Lagergren, K. , Othman, L. , Montgomery, S. , Andersson, G. & Tina, E. (2020). Evaluation of SPP1/osteopontin expression as predictor of recurrence in tamoxifen treated breast cancer. Scientific Reports, 10 (1). [BibTeX]
- Siekmann, W. , Tina, E. , Koskela von Sydow, A. & Gupta, A. (2019). Effect of lidocaine and ropivacaine on primary (SW480) and metastatic (SW620) colon cancer cell lines. Oncology Letters, 18 (1), 395-401. [BibTeX]
- Tina, E. , Prosén, S. , Lennholm, S. , Gasparyan, G. , Lindberg, M. & Göthlin Eremo, A. (2019). Expression profile of the amino acid transporters SLC7A5, SLC7A7, SLC7A8 and the enzyme TDO2 in basal cell carcinoma. British Journal of Dermatology, 180 (1), 130-140. [BibTeX]
- Cajander, S. , Rasmussen, G. , Tina, E. , Magnuson, A. , Söderquist, B. , Källman, J. & Strålin, K. (2018). Dynamics of monocytic HLA-DR expression differs between bacterial etiologies during the course of bloodstream infection. PLOS ONE, 13 (2). [BibTeX]
- Prosén, S. , Göthlin Eremo, A. , Tsegai, A. D. , Lindberg, M. & Tina, E. (2017). Decreased expression of the mitochondrial solute carrier SLC25A43 in basal cell carcinoma compared with healthy skin. Oncology Letters, 14 (2), 2218-2222. [BibTeX]
- Kuchalik, J. , Magnuson, A. F. , Tina, E. & Gupta, A. (2017). Does local infiltration analgesia reduce peri-operative inflammation following total hip arthroplasty?: A randomized, double-blind study. BMC Anesthesiology, 17. [BibTeX]
- Fant, F. , Tina, E. , Andersson, S. O. , Magnuson, A. , Hultgren Hörnquist, E. & Gupta, A. (2017). Early perioperative immunological effects of anaesthesia and analgesia in patients undergoing prostate cancer surgery: A randomised pilot study.. European Journal of Anaesthesiology, 34 (4), 241-243. [BibTeX]
- Gabrielson, M. , Reizer, E. , Stål, O. & Tina, E. (2016). Mitochondrial regulation of cell cycle progression through SLC25A43. Biochemical and Biophysical Research Communications - BBRC, 469 (4), 1090-1096. [BibTeX]
- Cajander, S. , Tina, E. , Bäckman, A. , Magnuson, A. , Strålin, K. , Söderquist, B. & Källman, J. (2016). Quantitative Real-Time Polymerase Chain Reaction Measurement of HLA-DRA Gene Expression in Whole Blood Is Highly Reproducible and Shows Changes That Reflect Dynamic Shifts in Monocyte Surface HLA-DR Expression during the Course of Sepsis. PLOS ONE, 11 (5). [BibTeX]
- Göthlin Eremo, A. , Tina, E. , Wegman, P. , Stål, O. , Fransén, K. , Fornander, T. & Wingren, S. (2015). HER4 tumor expression in breast cancer patients randomized to treatment with or without tamoxifen. International Journal of Oncology, 47 (4), 1311-1320. [BibTeX]
- Cajander, S. , Bäckman, A. , Tina, E. , Strålin, K. , Söderquist, B. & Källman, J. (2013). Preliminary results in quantitation of HLA-DRA by real-time PCR: a promising approach to identify immunosuppression in sepsis. Critical Care, 17 (5). [BibTeX]
- Gabrielson, M. & Tina, E. (2013). The mitochondrial transport protein SLC25A43 affects drug efficacy and drug-induced cell cycle arrest in breast cancer cell lines. Oncology Reports, 29 (4), 1268. [BibTeX]
- Fant, F. , Tina, E. , Sandblom, D. , Andersson, S. , Magnuson, A. , Hultgren-Hörnquist, E. , Axelsson, K. & Gupta, A. (2013). Thoracic epidural analgesia inhibits the neuro-hormonal but not the acute inflammatory stress response after radical retropubic prostatectomy. British Journal of Anaesthesia, 110 (5), 747-757. [BibTeX]
- Tina, E. , Lindqvist, B. M. , Gabrielson, M. , Lubovac, Z. , Wegman, P. & Wingren, S. (2012). The mitochondrial transporter SLC25A43 is frequently deleted and may influence cell proliferation in HER2-positive breast tumors. BMC Cancer, 12 (1). [BibTeX]
- Prenkert, M. , Uggla, B. , Tina, E. , Tidefelt, U. & Strid, H. (2009). Rapid Induction of P-Glycoprotein mRNA and Protein Expression by Cytarabine in HL-60 Cells. Anticancer Research, 29 (10), 4071-4076. [BibTeX]
- Tina, E. , Prenkert, M. , Höglund, M. , Paul, C. & Tidefelt, U. (2009). Topoisomerase IIalpha expression in acute myeloid leukaemia cells that survive after exposure to daunorubicin or ara-C. Oncology Reports, 22 (6), 1527-1531. [BibTeX]
- Uggla, B. , Tina, E. , Nahi, H. , Paul, C. , Höglund, M. , Sirsjö, A. & Tidefelt, U. (2007). Topoisomerase IIα mRNA and protein expression vs. in vitro drug resistance and clinical outcome in acute leukaemia. International Journal of Oncology, 31 (1), 153-160. [BibTeX]
- Gabrielson, M. , Reizer, E. , Ståhl, O. & Tina, E. (). Mitochondrial regulation of cell proliferation through SLC25A43 inHER2-positive breast cancer cells in vitro. . [BibTeX]
Artiklar, forskningsöversikter
- Fountoukidis, G. , Tina, E. , Göthlin Eremo, A. , Ullenhag, G. & Valachis, A. (2026). Optimizing the clinical assessment of pseudoprogression in patients with solid tumors treated with checkpoint inhibitors: a systematic literature review and meta-analysis of associated features. Cancer Immunology and Immunotherapy, 75 (6). [BibTeX]
Doktorsavhandlingar, sammanläggningar
- Tina, E. (2010). Biological markers in breast cancer and acute leukaemia with focus on drug resistance. (Doctoral dissertation). (Sammanläggning) Örebro: Örebro universitet. [BibTeX]
Konferensbidrag
- Lange, N. , Svenningsson, A. , Tina, E. , Hultgren, O. & Gunnarsson, M. (2025). Immunoglobulin-G dynamics and relation to antibiotic prescriptions in MS-patients treated with rituximab: a real-world cohort. I: Multiple Sclerosis Journal. Konferensbidrag vid 1st Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Barcelone, Spain, September 24-26, 2025. (ss. 1186-1186). Sage Publications. [BibTeX]
- Lange, N. , Gunnarsson, M. , Tina, E. , Hultgren, O. & Svenningsson, A. (2024). Prescription of Antibiotics in Patients with Multiple Sclerosis Treated with Rituximab: a 10-year Retrospective Cohort Study. I: Multiple Sclerosis Journal. Konferensbidrag vid 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, September 18-20, 2024. (ss. 484-484). Sage Publications. [BibTeX]
- Welander, E. , Åström, M. , Enonge Fotabe, L. , Kardeby, C. , Tina, E. , Elgbratt, K. , Pourlotfi, A. , Abawi, A. & et al. (2018). Integrated analysis indicates reciprocal immune response dysregulations between bone marrow multipotent stromal cells and granulocytes at the mRNA but not at the protein level in myelofibrosis. Konferensbidrag vid Fortbildningsdagar i hematologi, Umeå, 3-5 Oktober, 2018. [BibTeX]
- Siekmann, W. , Tina, E. & Gupta, A. (2017). Concentration-dependent cell viability and proliferation in vitro of colon cancer cell lines SW480 and SW620 on exposure to lidocaine or ropivacaine. I: Acta Anaesthesiologica Scandinavica. John Wiley & Sons. [BibTeX]
Manuskript
- Tina, E. , Malakkaran [Lindqvist ], B. P. , Gabrielson, M. , Lubovac, Z. , Karlsson, M. G. , Stål, O. , Wegman, P. & Wingren, S. A novel finding : SLC25A43 a solute carrier protein that is implicated in HER2 positive breast cancer. [BibTeX]
- Prosén, S. , Göthlin Eremo, A. , Seifert, O. , Lindberg, M. & Tina, E. Implications of LAT1 expression and inhibition in basal cell carcinoma and cutaneous squamous cell carcinoma. [BibTeX]
- Cajander, S. , Rasmussen, G. , Tina, E. , Magnuson, A. , Söderquist, B. , Källman, J. & Strålin, K. Monocytic HLA-DR expression differs between bacterial etiologies and is inversely related to C-reactive protein and neutrophil count during the course of bloodstream infection. [BibTeX]
- Gabrielson, M. , Göthlin Eremo, A. , Tina, E. , Karlsson, E. , Jakobsson, F. , Stål, O. & Wingren, S. Regulation of cell proliferation and recurrence-free survival in HER2-positive breast cancer through SLC25A43 and p27. [BibTeX]